remove Tagged Articles
Anemia drug for kidney patients pulled from market following deaths, hypersensitivity reactions
Omontys (peginesatide), an injection made by Takeda Pharmaceuticals and used to treat anemia due to chronic kidney disease in patients on dialysis, is being recalled and removed from the market because of serious hypersensitivity reactions, including anaphylaxis, some of which
Medical experts petitioned FDA to ban transvaginal mesh
“All too frequently, industry knowingly targets less experienced surgeons, knowing that these mesh have not, and will never be, accepted by more experienced surgeons who are fully aware of their inherent risk without benefit.”
FDA warns of potentially fatal heart rhythm abnormalities with anti-nausea drug for cancer patients
Zofran (ondansetron), a drug used to treat nausea and vomiting in cancer patients undergoing chemotherapy, may cause a potentially fatal heart rhythm, the Food and Drug Administration (FDA) warns.